Search results
Ad group WPP trails rivals with decline in organic revenue
Reuters via Yahoo News· 12 hours agoLONDON (Reuters) -Britain's WPP became a clear laggard among global ad companies with a drop in...
Pfizer (PFE) Rises Higher Than Market: Key Facts
Zacks· 4 days agoFree Report) closed at $26.26 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily gain of 0.87%. In that same time, the Medical sector ...
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Zacks· 2 days agoFree Report) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing ...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 days agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
Pfizer (PFE) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 2 days agoPfizer (NYSE:PFE – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 1st. Pfizer has set its ...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 2 days agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
J.W. Cole Advisors Inc. Boosts Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoJ.W. Cole Advisors Inc. raised its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 25.3% during the fourth quarter, according to its most recent disclosure with the Securities ...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 2 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Pfizer (NYSE:PFE) Trading 0.9% Higher
ETF DAILY NEWS· 5 days agoShares of Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.9% during mid-day trading on Friday . The stock traded as high as $25.66 and last traded at $25.62. 10,092,678 ...
